Genetic heterogeneity in breast cancer susceptibility

Acta Oncologica

Volumn 35, Issue 4, 1996, Pages 407-410

  Andersen, Tone Ikdahl ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; FEMALE; GENETIC HETEROGENEITY; HUMAN; PRIORITY JOURNAL;

EID: 0030057388     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609109913     Document Type: Article

References (35)

1. Lynch HT, Albano WA, Danes S, et al. Genetic predisposition to breast cancer. Cancer 1984; 53: 612-22.
2. Lynch HT, Watson P, Conway T, Fitzsimmons SL, Lynch J. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988; 11: 263-7.
3. Hodgson SV, Maher ER. Genetics of human cancers by site of origin. Reproductive system. Breast. In: A practical guide to human cancer genetics. Cambridge: Cambridge University Press, 1993: 58-63.
4. Ponder BAJ. Inherited predisposition to cancer. Trends Genet 1990; 6: 213-8.
5. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA. King M-C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-9.
6. Narod S, Feunteun J, Lynch HT, et al. Familial breastovarian cancer locus on chromosome 17q12-q23. Lancet 1991; 338: 82-3.
7. Hall JM, Friedman L, Guenther C, et al. Closing in on the breast cancer gene on chromosome 17q. Am J Hum Genet 1992; 50: 1235-42.
8. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer - results from 214 families. Am J Hum Genet 1993; 52: 678-701.
9. Easton DF, Ford D, Bishop DT, and the breast cancer linkage consortium. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995; 56: 265-71.
10. Stratton MR, Ford D, Neuhausen S, et al. Familial male breast cancer is not linked to the BRCA 1 locus on chromosome 17q. Nature Genet 1994; 7: 103-7.
11. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
12. Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-2.
13. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.
14. Schott DR, Chang JN, Deng G, et al. A candidate tumour suppressor gene in human breast cancers. Cancer Res 1994; 54: 1393-6.
15. Donehower LA, Bradley A. The tumour suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
16. Harris CC, Hollstein M. Clinical implications of the p53. tumorsuppressor gene. New Engl J Med 1993; 329: 1318-27.
17. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988; 48: 5358-62.
18. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-8.
19. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348: 747-9.
20. Birch JM, Hartley AL, Tricker KJ. et al. Prevalence and diversity of constitutional mutations in the pS3 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54: 1298-1304.
21. Børresen A-L, Andersen TI. Garbcr J, et al. Screening for germ-line TP53 mutations in breast cancer patients. Cancer Res 1992; 52: 3234-6.
22. Presser J, Porter D, Coles C, et al. Constitutional p53 mutation in a non-Li-Fraumeni cancer family. Br J Cancer 1992; 65: 527 8.
23. Sideransky D, Tokino T, Helzisouer K, et al. Inherited p53 gene mutations in breast cancer. Cancer Res 1992; 52: 2984 6.
24. Eeles R, Warren W, Knee G, et al. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Oncogene 1993; 8: 1269-76.
25. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE. Look AT. Splice-site mutation of the p53 gene in a family with hereditary breast ovarian cancer. Oncogene 1994; 9: 97-102.
26. Wooster R, Mangion J, Eeles R, et al. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nature Genet 1992; 2: 132-4.
27. Lobaccaro J-M, Lumbroso S, Belon C. et al. Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 1993: 11: 1799-1802.
28. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831-6.
29. Børresen A-L. Andersen TI, Tretli S, Heiberg A, Møller P. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chrom Cancer 1990; 2: 339-40.
30. Lange E. Børresen A-L, Chen X, et al. Localization of an A-T gene to a 750 kb interval on chromosome 11q23.1 by linkage analysis of 176 families in an international consortium. Am J Hum Genet 1995; 57: 112-9.
31. Menasce LP, White GRM, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and simple post-FISH banding technique. Genomics 1993; 17: 263-5.
32. Zuppan P, Hall JM, Lee MK, Ponglikitmongkol M, King M-C. Possible linkage of the estrogen receptor gene to breast cancer in a familyy with late-onset disease. Am J Hum Genet 1991; 48: 1065-8.
33. Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K. Børresen A-L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 1994; 94: 665-70.
34. Lehrer S, Levine E, Savoretti P. et al. Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 1992; 339: 1108-9.
35. Sobol H, Birnbaum D, Eisinger F. Evidence for a third breast-cancer susceptibility gene. Lancet 1994; 344: 1151-2.